The role of cholesterol management in coronary disease risk reduction in elderly patients

Endocrinology and Metabolism Clinics of North America

Volumn 27, Issue 3, 1998, Pages 655-675

  Grundy, S M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT;

CIGARETTE SMOKING; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; HYPERCHOLESTEROLEMIA; MEDICAL DECISION MAKING; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SECONDARY PREVENTION;

EID: 0031694244     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70032-3     Document Type: Article

References (85)

1. N. Abate G.L. Vega A. Garg Abnormal distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM Atherosclerosis 118 1995 111
2. The Aging Heart Its Function and Response to Stress 1980 Raven Press New York
3. American Diabetes Association Management of dyslipidemia in adults with diabetes Diabetes Care 21 1998 179
4. D. Aronson E.J. Rayfeld Diabetes and obesity Fuster V. Ross R. Topol E.J. Atherosclerosis and Coronary Artery Disease 1996 Lippincott-Raven Philadelphia
5. M.A. Austin Plasma triglyceride and coronary heart disease Arterioscler Thromb 11 1991 2
6. Bethesda Conference Report, 27th Bethesda Conference: Matching intensity on risk factor management with the hazard for coronary disease events J Am Coll Cardiol 27 1996 967
7. Brown B.G. Zhao X.-Q. J. Bardsley Secondary prevention of heart disease amongst patients with lipid abnormalities: Practice and trends in the United States J Intern Med 241 1997 283
8. Brown B.G. Zhao X.-Q. D.E. Sacco Lipid lowering and plaque regression: New insights into prevention of plaque disruption and clinical events in coronary disease Circulation 87 1993 1781
9. H. Buchwald R.L. Varco J.P. Matts Report of the Program on the Surgical Control of Hyperlipidemias (POSCH): Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia N Engl J Med 323 1990 946
10. W.P. Castelli W.F. Wilson D. Levy K. Anderson Cardiovascular risk factors in the elderly Am J Cardiol 63 1989 12H
11. P. Constantinides Plaque hemorrhages, their genesis and their role in supraplaque thrombosis and atherogenesis Glagov S. Newman W.P. Schaffer S.A. Pathobiology of the Human Atherosclerotic Plaque 1990 Springer-Verlag New York
12. M.C. Corti J.M. Guralnik M.E. Salive HDL cholesterol predicts coronary heart disease mortality in older persons JAMA 274 1995 539
13. J.A. Cutler B.M. Psaty S. MacMahon Public health issues in hypertension control: What has been learned from clinical trials Laragh J.H. Brenner B.M. Hypertension, Pathophysiology, Diagnosis, and Management 1995 Raven Press New York
14. G.H. Dahlen Lp(a) lipoprotein in cardiovascular disease Atherosclerosis 108 1994 111
15. M.J. Davies A macro and micro view of coronary vascular insult in ischemic heart disease Circulation 82 suppl II 1990 II-38
16. M.A. Denke S.M. Grundy Hypercholesterolemia in the elderly: Resolving the treatment dilemma Ann Intern Med 112 1990 780
17. M.A. Denke S.M. Grundy Efficacy of low-dose cholesterol lowering drug therapy in men with moderate hypercholesterolemia Arch Intern Med 155 1995 393
18. C. East D.W. Bilheimer S.M. Grundy Combination drug therapy for familial combined hyperlipidemia Ann Intern Med 109 1988 25
19. R.L.B. Ellen R. McPherson Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia Am J Cardiol 81 4A 1998 60B
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA 269 1993 3015
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: National Cholesterol Education Program: Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel II) Circulation 89 1994 1329
22. J.L. Fleg G. Gerstenblith A.B. Zonderman Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers Circulation 81 1990 428
23. W.H. Frishman A.N. DeMaria G.A. Ewy Clinical assessment J Am Coll Cardiol 10 1987 48A
24. A.M. Garber W.S. Browner Cholesterol screening guidelines: Consensus, evidence, and common sense Circulation 95 1997 1642
25. A.M. Garber W.S. Browner American College of Physicians Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults Ann Intern Med 124 1996 515
26. Genest J. Jr J.R. McNamara B. Upson Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease Arterioscler Thromb 11 1991 1129
27. R.F. Gillum Trends in acute myocardial infarction and coronary heart disease death in the United States J Am Coll Cardiol 23 1993 1273
28. J.L. Goldstein H.H. Hobbs M.S. Brown Familial hypercholesterolemia Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Diseases 1995 McGraw-Hill New York
29. D.J. Gordon Cholesterol lowering and total mortality Rifkind B.M. Lowering Cholesterol in High Risk Individuals and Populations 1955 Marcel Dekker New York
30. S.M. Grundy HMG-CoA reductase inhibitors for treatment of hypercholesterolemia N Engl J Med 319 1988 24
31. S.M. Grundy Cholesterol and coronary heart disease: The 21st century Arch Intern Med 157 1997 1177
32. S.M. Grundy Small LDL: Atherogenic dyslipidemia, and the metabolic syndrome Circulation 95 1997 1
33. S.M. Grundy Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome Am J Cardiol 81 4A 1998 18B
34. S.M. Grundy Statin trials and goals of cholesterol-lowering therapy Circulation 97 1998 1436
35. S.M. Grundy G.L. Vega Fibric acids: Effects on lipids and lipoprotein metabolism Am J Med 83 1987 9
36. S.M. Grundy G.L. Vega D.W. Bilheimer Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia Ann Intern Med 103 1985 339
37. T.R. Harrison The relation of age to the duration of contraction, ejection, and relaxation of the normal human heart Am Heart J 67 1964 189
38. B. Hermanson G.S. Omenn R.A. Kronmal Beneficial six-year outcome of smoking cessation in older men and women from coronary artery disease: Results from the CASS registry N Engl J Med 319 1988 1365
39. I. Jialal S.M. Grundy Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein J Lipid Res 33 1992 899
40. I. Jialal S.M. Grundy Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta-carotene on low-density lipoprotein oxidation Circulation 88 1993 2780
41. J.T. Judd B.A. Clevidence R.A. Muesing Dietary trans fatty acid: Effects on plasma lipids and lipoproteins of healthy men and women Am J Clin Nutr 59 1994 861
42. W.B. Kannel W.P. Castelli T. Gordon Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham Study Ann Intern Med 74 1971 1
43. N.M. Kaplan Clinical Hypertension 1990 Williams and Wilkins Baltimore
44. R.A. Kronmal K.C. Cain Z. Ye Total serum cholesterol levels and mortality risk as a function of age: A report based on the Framingham data Arch Intern Med 153 1994 1065
45. H.M. Krumholz T.E. Seeman S.S. Merrill Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years JAMA 272 1994 1335
46. E.G. Lakatta F.C.P. Yin Myocardial aging: Functional alterations and related cellular mechanisms Am J Physiol 242 1987 H927
47. P. Libby Molecular basis of the acute coronary syndrome Circulation 91 1995 2844
48. Lipid Research Clinics Program The Lipid Research Clinics coronary primary prevention trial results. I. Reduction in the incidence of coronary heart disease JAMA 251 1984 351
49. Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering JAMA 251 1984 365
50. D.J. Malenka J.A. Baron Cholesterol and coronary heart disease: The importance of patient-specific attributable risk Arch Intern Med 148 1988 2247
51. V. Manninen L. Tenkanen P. Koskinen Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: Implications for treatment Circulation 85 1992 37
52. R. Martin-Jadraque F. Tato J.M. Mostaza Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels Arch Intern Med 156 1996 1081
53. McGill H.C. Jr C.A. McMahan A.W. Kruski Relationship of lipoprotein cholesterol concentrations to experimental atherosclerosis in baboons Arteriosclerosis 1 1981 3
54. R.P. Mensink M.B. Katan Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects N Engl J Med 323 1990 439
55. T.R. Miller S.J. Grossman K.B. Schetman Left ventricular diastolic filling in the healthy elderly Am J Cardiol 58 1986 531
56. M. Moser P. Hebert C. Hennekens An overview of the meta-analysis of the hypertension treatment trials Arch Intern Med 151 1991 1277
57. J.M. Mostaza I. Schulz G.L. Vega Comparison of pravastatin with crystalline nicotinic acid monotherapy in treatment of combined hyperlipidemia Am J Cardiol 79 1997 1298
58. J. Nadelmann W.H. Frishman W.L. Ooi Prevalance, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging Study Am J Cardiol 66 1990 533
59. National Diabetes Data Group: Diabetes in America. NIH Publication No. 95-1468, ed 2. Bethesda, MD, NIH/NIDDK, 1995.
60. E.A. Nikkila R. Ylikahri J.K. Huttunen Gemfibrozil: Effect on serum lipids, lipoproteins, and postheparin plasma lipase activity and glucose tolerance in primary hypertriglyceridemia Proc R Soc Med 69 1976 258
61. C.L. Pashos J.P. Newhouse B.J. McNeil Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990 JAMA 270 1993 1832
62. Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking JAMA 264 1990 3018
63. M.S. Pathy Clinical presentation of myocardial infarction in the elderly Br Heart J 29 1967 190
64. T.R. Pedersen A.G. Olsson O. Faergeman Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation 97 1998 1453 1460
65. J. Pekkanen S. Linn G. Heiss Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease N Engl J Med 322 1990 1700
66. The Post Coronary Artery Bypass Graft Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts N Engl J Med 336 1997 153
67. G.M. Reaven Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart disease Am Heart J 121 1991 1283
68. M.W. Rich M.S. Bosner M.K. Chung Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med 92 1992 7
69. J.E. Rossouw B. Lewis B.M. Rifkind The value of lowering cholesterol after myocardial infarction N Engl J Med 323 1990 1112
70. F.M. Sacks L.A. Moye B.R. Davis Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial Circulation 97 1998 1446 1452
71. F.M. Sacks M.A. Pfeffer L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001
72. S.P. Schulman M.W. Weisfeldt Cardiovascular aging and adaptation to disease Schlant R.C. Alexander R.W. The Heart, Arteries, and Veins 1994 McGraw-Hill New York
73. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255
74. J. Shepherd S.M. Cobbe I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia N Engl J Med 333 1995 1301
75. Smith S.C. Jr S.N. Blair M.H. Criqui Preventing heart attack and death in patients with coronary disease Circulation 92 1995 2
76. S.C. Smith E. Gilpin S. Ahnue Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years J Am Coll Cardiol 16 1990 784
77. R.S. Stafford C.G. Becker Cigarette smoking and atherosclerosis Fuster V. Ross R. Topol E.J. Atherosclerosis and Coronary Artery Disease 1996 Lippincott-Raven Philadelphia
78. M.J. Stampfer M.R. Malinow W.C. Willett A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians JAMA 268 1992 877
79. D. Steinberg Lewis A Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis Circulation 95 1997 1062
80. Strong J.P. Oalmann M.C. Malcom G.T. the Pathological Determinants of Atherosclerosis in Youth (PDAY) Research Group Pathobiological determinants of atherosclerosis in youth (PDAY): The rationale, methodology, and selected risk factor findings Cardiovasc Risk Factors 2 1992 22
81. Tonkin A: The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) study [abstract]. Presented at the 70th Scientific Sessions of the American Heart Association. Orlando, FL, November 12, 1997.
82. G.L. Vega S.M. Grundy Influence of lovastatin therapy on the metabolism of low density lipoproteins in mixed hyperlipidemia J Intern Med 230 1991 341
83. G.L. Vega S.M. Grundy Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol JAMA 257 1987 33
84. G.L. Vega S.M. Grundy Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia Arteriosclerosis and Thrombosis 13 1993 579
85. P. Zimetbaum W.H. Frishman W.L. Ooi Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly: The Bronx Aging Study Arteriosclerosis and Thrombosis 12 1992 416